Oak Therapeutics Announces Results of Bioequivalence Study of Company’s Oral Dissolvable Strip for Tuberculosis
Results of In Vivo Study Signifies Completion of another Critical Milestone in Company’s Phase I of NIAID Contract* to Develop ...
Tag: CURE Pharmaceutical
CURE Pharmaceutical Moves to OTCQB Exchange
OXNARD, Calif., Jan. 24, 2017 (GLOBE NEWSWIRE) -- CURE Pharmaceutical (OTC Pink:CURR), a preeminent developer and manufacturer of advanced oral ...
© Copyright 2022 publicwire.com